Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much as $62 million, as the biotech company keeps its eye on its non-hallucinogenic treatments. The agreement grants MycoMedica exclusive global rights to EB-002, a synthetic prodrug …
Parkinson’s Disease patients find hope in lobby of Playhouse Square
Nearly one million people in the U.S. are living with Parkinson’s Disease. Playhouse Square is rolling out a new program to help a growing number of patients.It’s important outreach because the number of cases in the U.S. is expected to rise to 1.2 million over the next five years.Last month, I circled back with the
Trump plans to revoke many Biden policies. Where does that leave cannabis? – OPB
A “weed” sign advertises a cannabis dispensary in Los Angeles. With a new Trump administration coming into the White House, marijuana could remain on …
Number of the Week: 43%
43% – How much the AdvisorShares Pure US Cannabis ETF declined in the past week Cannabis investors had high hopes for the election last Tuesday, with strong optimism that Florida would join the ranks of adult-use cannabis states. While a majority of voters approved the measure, Amendment 3 ultimately fell …